Engrave Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,076
| Closed | -$222K | – | 71 |
|
|
2022
Q4 | $222K | Buy |
3,076
+227
| +8% | +$16.4K | 0.08% | 65 |
|
|
2022
Q3 | $203K | Hold |
2,849
| – | – | 0.09% | 57 |
|
|
2022
Q2 | $219K | Buy |
2,849
+7
| +0.2% | +$538 | 0.1% | 53 |
|
|
2022
Q1 | $208K | Buy |
+2,842
| New | +$208K | 0.08% | 53 |
|
|
2021
Q3 | – | Sell |
-4,275
| Closed | -$286K | – | 71 |
|
|
2021
Q2 | $286K | Buy |
4,275
+139
| +3% | +$9.3K | 0.09% | 63 |
|
|
2021
Q1 | $261K | Buy |
4,136
+242
| +6% | +$15.3K | 0.11% | 58 |
|
|
2020
Q4 | $252K | Buy |
+3,894
| New | +$252K | 0.21% | 49 |
|
|
2020
Q3 | – | Sell |
-3,373
| Closed | -$198K | – | 98 |
|
|
2020
Q2 | $198K | Hold |
3,373
| – | – | 0.18% | 50 |
|
|
2020
Q1 | $188K | Hold |
3,373
| – | – | 0.22% | 40 |
|
|
2019
Q4 | $216K | Buy |
+3,373
| New | +$216K | 0.21% | 42 |
|